Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Cardiology · Arrhythmogenic Cardiomyopathy

Living with ACM: Family, Pregnancy, and Emotional Support

At a Glance

Arrhythmogenic cardiomyopathy (ACM) requires comprehensive management that extends beyond the individual patient. Because ACM is hereditary, family members need cascade genetic screening. Patients should build an expert multidisciplinary care team to navigate complex decisions around pregnancy, physical activity, and mental well-being.

Managing Arrhythmogenic Cardiomyopathy (ACM) is a marathon, not a sprint. Because this condition is progressive and hereditary, your care must extend beyond yourself to include your family, and it must address your mental well-being as much as your physical heart health [1][2].

Building Your Medical Care Team

Because ACM is a complex, rare disease, you need more than a general cardiologist. An expert care team should be multidisciplinary and include [3][4]:

  • Electrophysiologist (EP): A heart rhythm specialist who manages your arrhythmias, medications, and your ICD [5][1].
  • Genetic Counselor: A specialist who helps interpret your genetic test results and coordinates screening for relatives [6][7].
  • Imaging & Heart Failure Specialists: Cardiologists with expertise in reading Cardiac MRIs and managing long-term heart muscle weakness [8][9].
  • Cardio-Obstetrician: (If applicable) A specialist in managing heart conditions during pregnancy.

Vetting Your Team

Consider asking these three “expert-check” questions:

  1. “Do you use the 2020 Padua Criteria to monitor for left-sided heart involvement?”
  2. “How many patients with inherited cardiomyopathies do you see in a typical month?”
  3. “Do you have experience performing epicardial (outside the heart) ablations if my arrhythmias become difficult to manage?”

Family Screening: The Cascade Process

If you have been diagnosed with ACM, your “first-degree” relatives (parents, siblings, and children) have a 50% chance of carrying the same genetic mutation [10][11]. This is managed through cascade screening [12].

  • Genetic Testing: Relatives should be tested for your specific “pathogenic” mutation [10][13].
  • Pediatric Screening: Screening for children often starts around age 10–12. For parents, this can be terrifying, but the screening itself is usually completely painless. It typically involves listening to the heart, a simple ECG (stickers on the chest to check the electrical rhythm), and an echocardiogram (a non-invasive ultrasound jelly test). Intravenous MRIs are rarely the first step for young children unless specific symptoms appear [14][15].
  • Frequency: Asymptomatic gene carriers typically need a non-invasive cardiac check-up every 1 to 3 years [15][16].

Pregnancy and Family Planning

Because ACM affects young adults, family planning is a major consideration.

  • Pregnancy Risks: The increased blood volume and heart rate during pregnancy place extra hemodynamic stress on the heart, which can exacerbate ACM symptoms or arrhythmias [1][2].
  • Medications: Some antiarrhythmic medications and heart failure drugs are not safe during pregnancy and must be adjusted beforehand. Beta-blockers are generally continued [1].
  • Genetics: Since there is a 50% chance of passing the gene to a child, parents can opt to speak with a genetic counselor about Preimplantation Genetic Testing (PGT). This is a process used during IVF to ensure only embryos without the ACM mutation are implanted [6][7].

Living with ACM: The Psychological Impact

A diagnosis of ACM often comes with a significant psychological burden. It is common to experience:

  • Scan Anxiety: Worrying about results leading up to your annual MRI [17].
  • Fear of Shock: For those with an ICD, the fear of the device delivering a shock can lead to severe anxiety or PTSD [18][19].
  • Identity Shift: Adjusting to “the new normal,” especially for former athletes who must stop doing the sports they love [2][20].

Support is essential. Many patients find it helpful to work with a cardiac psychologist—a therapist who specializes in the unique emotional challenges of living with heart disease [21][22]. Connecting with patient advocacy groups (like SADS or the ARVC Foundation) can also help you realize you are not alone in this journey.

Common questions in this guide

Who should be on my arrhythmogenic cardiomyopathy (ACM) care team?
Your care team should include an electrophysiologist to manage your heart rhythm, a genetic counselor to coordinate family testing, and imaging specialists for regular monitoring. If you are planning a pregnancy, you should also include a cardio-obstetrician.
What is cascade screening for ACM?
Cascade screening is a process used to test the first-degree relatives of someone diagnosed with ACM. Because there is a 50 percent chance of passing the genetic mutation to parents, siblings, or children, these family members should undergo genetic testing and regular non-invasive cardiac evaluations.
Is it safe to get pregnant if I have ACM?
Pregnancy with ACM is possible but requires careful planning. Increased blood volume during pregnancy places extra stress on the heart, which can worsen arrhythmias. You must work closely with a cardio-obstetrician to adjust your heart medications beforehand and monitor your health throughout the pregnancy.
How can I avoid passing the ACM gene to my children?
Prospective parents can consult a genetic counselor about Preimplantation Genetic Testing (PGT). This procedure is performed alongside in vitro fertilization (IVF) to ensure that only embryos without the ACM genetic mutation are implanted, preventing the condition from being passed to the child.
How do I cope with the anxiety of living with an ICD?
Living with an implantable cardioverter-defibrillator (ICD) can cause significant anxiety and a fear of receiving a shock. Working with a specialized cardiac psychologist and joining patient advocacy groups can provide effective strategies to manage this stress and adjust to your diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with ACM do you currently manage, and do you have a specific expertise in my genetic subtype (e.g., DSP or PKP2)?
  2. 2.Does your center have a dedicated inherited cardiomyopathy program that includes both an electrophysiologist and a genetic counselor?
  3. 3.Based on my specific mutation and family history, what is the recommended screening schedule (and at what age) for my children?
  4. 4.If I am planning to become pregnant, do we need to refer me to a Cardio-Obstetrician or adjust my medications?
  5. 5.If I experience significant anxiety or 'fear of shock' regarding my ICD, do you have a cardiac psychologist or counselor you recommend?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.

    Goff ZD, Calkins H

    Progress in cardiovascular diseases 2019; (62(3)):217-226 doi:10.1016/j.pcad.2019.04.002.

    PMID: 31004608
  2. 2

    [Arrhythmogenic right ventricular cardiomyopathy : An update].

    Marchetti M, Pascale P, Muller O, Lu H

    Annales de cardiologie et d'angeiologie 2022; (71(4)):223-227 doi:10.1016/j.ancard.2022.08.006.

    PMID: 36089416
  3. 3

    Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria.

    Corrado D, Perazzolo Marra M, Zorzi A, et al.

    International journal of cardiology 2020; (319()):106-114 doi:10.1016/j.ijcard.2020.06.005.

    PMID: 32561223
  4. 4

    2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary.

    Towbin JA, McKenna WJ, Abrams DJ, et al.

    Heart rhythm 2019; (16(11)):e373-e407 doi:10.1016/j.hrthm.2019.09.019.

    PMID: 31676023
  5. 5

    Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.

    Mathew S, Saguner AM, Schenker N, et al.

    Journal of the American Heart Association 2019; (8(5)):e010365 doi:10.1161/JAHA.118.010365.

    PMID: 30813830
  6. 6

    Recognizing a "Hot Phase" of An Arrhythmogenic Left Ventricular Cardiomyopathy: A Case Report.

    Cabral M, Fernandes S, Ruivo C, et al.

    Journal of the Saudi Heart Association 2023; (35(3)):232-234 doi:10.37616/2212-5043.1348.

    PMID: 37881594
  7. 7

    Desmoplakin cardiomyopathy: recent updates in natural history and management.

    Hoffman-Andrews L, Anderson OG, Owens AT

    Current opinion in cardiology 2025; (40(5)):375-380 doi:10.1097/HCO.0000000000001240.

    PMID: 40600431
  8. 8

    Clinical and genetic features of arrhythmogenic cardiomyopathy: diagnosis, management and the heart failure perspective.

    Castrichini M, Eldemire R, Groves DW, et al.

    Progress in pediatric cardiology 2021; (63()) doi:10.1016/j.ppedcard.2021.101459.

    PMID: 34970070
  9. 9

    Rapid progression of right ventricular dysfunction: a case report.

    Li G, Zhao C, Wu L, Yan Y

    BMC cardiovascular disorders 2025; (25(1)):157 doi:10.1186/s12872-025-04601-2.

    PMID: 40055607
  10. 10

    Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management.

    Yogasundaram H, Alhumaid W, Dzwiniel T, et al.

    The Canadian journal of cardiology 2021; (37(4)):547-559 doi:10.1016/j.cjca.2021.01.016.

    PMID: 33493662
  11. 11

    Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

    Akdis D, Brunckhorst C, Duru F, Saguner AM

    Arrhythmia & electrophysiology review 2016; (5(2)):90-101 doi:10.15420/AER.2016.4.3.

    PMID: 27617087
  12. 12

    [Genetic testing to prevent sudden cardiac death].

    Stallmeyer B, Dittmann S, Schulze-Bahr E

    Der Internist 2018; (59(8)):776-789 doi:10.1007/s00108-018-0462-x.

    PMID: 29943240
  13. 13

    Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India.

    Chockalingam P, Geetha TS, Nair S, et al.

    Indian heart journal 2024; (76(4)):260-267 doi:10.1016/j.ihj.2024.07.002.

    PMID: 39009076
  14. 14

    Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.

    Smedsrud MK, Chivulescu M, Forså MI, et al.

    European heart journal 2022; (43(45)):4694-4703 doi:10.1093/eurheartj/ehac485.

    PMID: 36036653
  15. 15

    Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging.

    Haugaa KH, Basso C, Badano LP, et al.

    European heart journal. Cardiovascular Imaging 2017; (18(3)):237-253 doi:10.1093/ehjci/jew229.

    PMID: 28069601
  16. 16

    Arrhythmogenic Right Ventricular Cardiomyopathy: The Role of Genetics in Diagnosis, Management, and Screening.

    Odak M, Douedi S, Mararenko A, et al.

    Cardiology research 2022; (13(4)):177-184 doi:10.14740/cr1373.

    PMID: 36128418
  17. 17

    Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.

    Wang W, Cadrin-Tourigny J, Bhonsale A, et al.

    Journal of cardiovascular electrophysiology 2018; (29(10)):1396-1402 doi:10.1111/jce.13668.

    PMID: 29894017
  18. 18

    [Redetection of tachycardia in severe ventricular undersensing].

    Steffel J

    Herzschrittmachertherapie & Elektrophysiologie 2016; (27(3)):240-3 doi:10.1007/s00399-016-0445-3.

    PMID: 27459975
  19. 19

    Subcutaneous Implantable Cardioverter-Defibrillator and Arrhythmogenic Right Ventricular Cardiomyopathy: The Importance of Repeat ECG Screening During Exercise Test.

    Migliore F, Bertaglia E, Zorzi A, Corrado D

    JACC. Clinical electrophysiology 2017; (3(7)):785-786 doi:10.1016/j.jacep.2016.10.014.

    PMID: 29759546
  20. 20

    Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

    Wang W, Orgeron G, Tichnell C, et al.

    Journal of the American Heart Association 2018; (7(12)) doi:10.1161/JAHA.118.008843.

    PMID: 29909402
  21. 21

    Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.

    Christensen AH, Platonov PG, Svensson A, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(2)):306-312 doi:10.1093/europace/euab112.

    PMID: 34279601
  22. 22

    Patient Preferences in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Screening and ICD Implantation: Canadian ARVC Registry Substudy.

    Carroll SL, Pullman D, Gardner M, et al.

    CJC open 2025; (7(1)):27-34 doi:10.1016/j.cjco.2024.10.007.

    PMID: 39872644

This page provides educational information about living with and managing arrhythmogenic cardiomyopathy. It is not a substitute for professional medical advice; always consult your cardiologist or genetic counselor regarding your family planning or treatment needs.

Get notified when new evidence is published on Inherited arrhythmogenic cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.